Hybrigenics SA Logo

Hybrigenics SA

Provider of technologies for studying molecular interactions and antibody selection.

ALHYG | PA

Overview

Corporate Details

ISIN(s):
FR0004153930
LEI:
9695003KQD0XMJYDX764
Country:
France
Address:
850 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN

Description

Hybrigenics Services is a specialized provider of technologies for studying molecular interactions. Its core offering is the ULTImate Y2H™ platform, a comprehensive Yeast Two-Hybrid system used to discover protein-protein interactions, as well as interactions with DNA, RNA, and small molecules. This technology is applied to drug discovery for target deconvolution and identifying molecular glues. A second key service is the Hybribody platform, which leverages a proprietary synthetic library for the custom selection, validation, and optimization of single-domain antibodies (VHHs/Nanobodies). The company serves clients in fundamental research, pharmaceutical R&D, and agroscience.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 18:00
RESULTATS SEMESTRIELS 2025
French 212.4 KB
2025-10-08 18:00
ATON ANNONCE UN PARTENARIAT ENTRE SA FILIALE INOVIEM SCIENTIFIC ET LA SOCIETE S…
French 263.7 KB
2025-09-29 08:00
ATON PARTICIPE AU EUROPEAN MIDCAP EVENT 2025 À PARIS LES 30 SEPTEMBRE et 1ER OC…
French 254.1 KB
2025-09-17 18:00
PIMS TECHNOLOGY LEVE 500 K EUR AUPRES DE BPIFRANCE ET PREPARE UN TOUR DE TABLE …
French 284.0 KB
2025-09-10 18:05
ATON SE FELICITE DU PARTENARIAT STRATEGIQUE ENTRE LOGICAL BIOLOGICAL ET SA FILI…
French 239.1 KB
2025-09-03 18:00
ATON MET EN LUMIERE LA DYNAMIQUE DE SES FILIALES ET AMORCE UNE NOUVELLE PHASE D…
French 252.3 KB
2025-04-30 18:00
RÉSULTATS ANNUELS CONSOLIDÉS 2024
French 290.7 KB
2024-10-31 18:00
RÉSULTATS SEMESTRIELS 2024
French 187.0 KB
2024-10-01 18:30
Assemblée générale mixte du 30 septembre 2024 : Approbation des comptes annuels…
French 272.4 KB
2024-07-18 18:00
ATON FINALISE AVEC SUCCES SA RESTRUCTURATION FINANCIERE
French 283.7 KB
2024-06-17 18:30
ASSEMBLEE GENERALE ORDINAIRE LE 2 JUILLET 2024
French 142.5 KB
2024-06-07 18:30
ENGAGEMENT DE DISCUSSIONS AVEC LES CREANCIERS EN VUE D'ASSAINIR LA SITUATION FI…
French 148.9 KB
2024-04-30 18:30
RÉSULTATS ANNUELS 2023 - REPORT DE LA PUBLICATION DU RAPPORT ANNUEL 2023
French 248.9 KB
2024-03-07 18:00
ÉCHELONNEMENT DU REMBOURSEMENT DE L'EMPRUNT OBLIGATAIRE CONVERTIBLE DE 1,5 M EU…
French 240.5 KB
2024-02-22 18:00
2023 : une année de profondes transformations - Situation de trésorerie au 31 d…
French 282.3 KB

Automate Your Workflow. Get a real-time feed of all Hybrigenics SA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hybrigenics SA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hybrigenics SA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.